Tissue Regenix Group

Tissue Regenix was established in May 2006 and is dedicated to the development of clinical solutions to address the chronic shortfalls in donor tissue availability in areas such as Vascular and Orthopaedic medicine. There is a well established clinical need for more donor tissue for many surgical procedures. Tissue Regenix will develop and commercialise acellular tissue repair products to meet this need, to ultimately benefit patients.
Type
Public
HQ
Swillington, GB
Founded
2006
Size (employees)
70 (est)+17%
Tissue Regenix Group was founded in 2006 and is headquartered in Swillington, GB

Tissue Regenix Group Office Locations

Tissue Regenix Group has offices in Swillington, San Antonio
Swillington, GB
San Antonio, US

Tissue Regenix Group Metrics

Tissue Regenix Group Summary

Market capitalization

£115.2 m

Closing share price

£0.2
Tissue Regenix Group's current market capitalization is £115.2 m.

Tissue Regenix Group Financials

Tissue Regenix Group's revenue is £6 k in FY, 2014 which is a 94% decrease from the previous period.
FY, 2014FY, 2015FY, 2016

Revenue

£6 k£100 k£816 k

Revenue growth, %

1566.7%716%

Cost of sales

£32 k£154 k

Gross profit

£68 k£662 k

Gross profit Margin, %

68%81.1%

Operating expense total

£8.4 m£10.9 m

Tissue Regenix Group Market Value History

We estimate that Tissue Regenix Group's current employees are approximately 27% female and 73% male.

Tissue Regenix Group Online Presence

Tissue Regenix Group News

Tissue Regenix Group Company Life

You may also be interested in